Semaglutide
For Research Use Only · Not for Human Consumption
Weight lossMetabolic
Semaglutide is a 31-amino-acid GLP-1 analogue modified with a C18 fatty-acid chain for extended albumin binding. It is widely used in laboratory studies of GLP-1 receptor signalling, β-cell response and in-vitro models of energy balance. Supplied as lyophilized powder at ≥98% HPLC purity. For Research Use Only. Not for Human Consumption. Not a drug, food, or cosmetic.
Potential benefits — preclinical research
- •~15% mean body-weight reduction at 68 weeks in the STEP-1 trial.
- •Reduced HbA1c and post-prandial glucose in T2D research populations.
- •Slowed gastric emptying and reduced appetite scores in human studies.
- •Cardiovascular risk-marker improvements (LDL, blood pressure) reported in trial sub-analyses.
Findings reported in published in-vitro / animal studies. Not therapeutic claims — for research use only.
Certificate of Analysis
View certificateOut of stock
—per vial